Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years (Q27687622)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years |
scientific article |